semaglutide vs tirzepatide weight loss efficacy comparison Why is a better option than for Frontiers | Tirzepatide vs. semaglutide

CagriSema vs Comparators Feature Receptor targets CagriSema Amylin/calcitonin + GLP-1 Tirzepatide (Zepbound) GIP + GLP-1 Semaglutide alone (Wegovy) GLP-1 Cagrilintide alone Amylin/calcitonin (DACRA) Feature Dosing frequency CagriSema Once weekly Tirzepatide (Zepbound) Once weekly Semaglutide alone (Wegovy) Once weekly Cagrilintide alone Once weekly Feature Maintenance dose CagriSema 2.4 mg + 2.4 mg Tirzepatide (Zepbound) Up to 15 mg Semaglutide alone (Wegovy) 2.4 mg Cagrilintide alone 2.4 mg (in REDEFINE arms) Feature Headline weight loss CagriSema 20.4% at 68 wks (REDEFINE 1, treatment-policy) Tirzepatide (Zepbound) Up to 22.5% at 72 wks (SURMOUNT-1, 15 mg arm) Semaglutide alone (Wegovy) 14.9% at 68 wks (REDEFINE 1 reference arm) Cagrilintide alone 11.5% at 68 wks (REDEFINE 1 reference arm) Feature FDA status (June 2026) CagriSema NDA filed Dec 2025

It is studied for its ability to stimulate melanogenesis (skin tanning), influence libido, and activate melanocortin receptors in the brain and skin

( 5.3) Substantial weight loss can increase the risk of cholelithiasis

The FLOW trial of semaglutide versus placebo for kidney outcomes was stopped early due to evidence of kidney protection

Los efectos secundarios ms comunes de Ozempic en adultos incluyen nuseas, diarrea, vmitos, dolor estomacal (abdominal) y estreimiento

Always consult with your primary care physician or our clinical partners at Celia Health to undergo proper medical screening before beginning any peptide therapy